Samarium-153
Intended use
It is used in oncology for the purpose of sustained reduction in the intensity of pain syndrome caused by the presence of metastatic bone lesions, as well as for rheumatic patients with pronounced pain syndrome. Additionally, Sm-153 is highly effective in the diagnosis and treatment of prostate and breast cancer.
Grade:
1. Non-carrier added radionuclide;
2. GMP product;
3. Tested for sterility and bacterial endotoxins.
Appearance: transparent, clear colorless solution
Half-life period: 1.93 days
Concentrations, mg/ml: 15.0−25.0
Radiochemical purity ≥ 95%
Radionuclide Impurities, %: ≤ 3×10^-3
Content of Sodium Chloride, mg/ml: 4.0−6.0
It is used in oncology for the purpose of sustained reduction in the intensity of pain syndrome caused by the presence of metastatic bone lesions, as well as for rheumatic patients with pronounced pain syndrome. Additionally, Sm-153 is highly effective in the diagnosis and treatment of prostate and breast cancer.
Grade:
1. Non-carrier added radionuclide;
2. GMP product;
3. Tested for sterility and bacterial endotoxins.
Appearance: transparent, clear colorless solution
Half-life period: 1.93 days
Concentrations, mg/ml: 15.0−25.0
Radiochemical purity ≥ 95%
Radionuclide Impurities, %: ≤ 3×10^-3
Content of Sodium Chloride, mg/ml: 4.0−6.0
Other products
